4.5 Interaction with other medicinal products and other forms of interaction 
 No in vivo  interaction studies have been performed.   
 In vitro  binding studies have not shown interference of florbetapir (18F) binding to Î² -amyloid plaques in the presence of other common medicinal products taken by AD patients.  
 
